Addiction Medicine Practice-Based Research Network (AMNet): Assessment Tools and Quality Measures.
Diana E. Clarke,Adila Ibrahim,Benjamin Doty,Sejal Patel,Debbie Gibson,Anna Pagano,Laura Thompson,Amy B Goldstein,Frank Vocci,Robert P. Schwartz +9 more
TLDR
The Addiction Medicine Practice-Based Research Network (AMNet) was developed to facilitate the uptake of MBC in outpatient practices via implementation of patient-reported assessments and quality of care performance measures to improve patient outcomes as discussed by the authors.Abstract:
Introduction The need for innovative approaches to address the opioid epidemic in the United States is widely recognized. Many challenges exist to addressing this epidemic, including the obstacles outpatient substance use treatment practices face in implementing measurement-based care (MBC), quality measurement systems, and evidence-based treatments. Also, there are insufficient opportunities for clinicians in these settings to participate in research, resulting in diminished translation of research findings into community-based practice. To address these challenges, the Addiction Medicine Practice-Based Research Network (AMNet) was developed to facilitate the uptake of MBC in outpatient practices via implementation of patient-reported assessments and quality of care performance measures to improve patient outcomes. This network will offer clinicians in outpatient settings (not incuding opioid treatment programs [OTPs]) the opportunity to participate in future substance use disorder treatment research studies. Methods A key step in the development of AMNet was the selection of substance use-specific assessment tools and quality of care performance measures for incorporation into the American Psychiatric Association's mental health patient registry, PsychPRO. A scoping review and multi-step consensus-based process were used to identify, review and select candidate assessment tools and quality of care performance measures for opioid use disorders (OUD) and substance use disorders (SUD). Results Following a consensus-based methodology, 12 standardized assessment tools and 3 quality of care performance measures for OUD and SUD were selected to help facilitate the implementation of MBC and quality improvement for AMNet participants. These tools were further categorized as core and optional. Conclusion By offering a collection of carefully vetted assessment tools and quality measures through PsychPRO, AMNet will help participating clinicians with the systematic uptake of MBC and delivery of evidence-based treatment for patients with SUD. Also, AMNet will act as a centralized repository of data collected from patients and clinicians in non-OTP outpatient addiction medicine practices and serve as a platform for opioid treatment research.read more
Citations
More filters
Journal ArticleDOI
The opioid use disorder core outcomes set (OUD–COS) for treatment research: findings from a Delphi consensus study
Niranjan S. Karnik,John Marsden,Connor McCluskey,Randy A. Boley,Katharine A. Bradley,Cynthia I. Campbell,Megan E. Curtis,David A. Fiellin,Udi E. Ghitza,Kathryn R. Hefner,Yih-Ing Hser,R. Kathryn McHugh,Sterling McPherson,Larissa J. Mooney,Landhing M. Moran,Sean M. Murphy,Robert S. Schwartz,Dikla Shmueli-Blumberg,Matisyahu Shulman,Kari A. Stephens,Katherine E. Watkins,Roger D. Weiss,Li-Tzy T. Wu +22 more
TL;DR: An e‐Delphi consensus study has produced the US National Institute on Drug Abuse (NIDA) National Drug Abuse Treatment Clinical Trials Network opioid use disorder core outcomes set (version 1) for opioid use Disorder treatment efficacy and effectiveness research.
Journal ArticleDOI
Longitudinal associations between pain and substance use disorder treatment outcomes.
Erin G. Ferguson,Ben Lewis,Scott A. Teitelbaum,Gary M. Reisfield,Michael E. Robinson,Jeff Boissoneault +5 more
TL;DR: In this paper , the authors examined the trajectory of pain over the course of substance use disorder treatment and associations with substance use outcomes and found that participants with OUD had greater reductions in pain intensity and interference over time compared to those without OUD.
Journal ArticleDOI
Improving assessment and progress monitoring in alcohol use disorder: An implementation evaluation of the instant assessment and personalised feedback system (iAx).
TL;DR: In this paper , an instant assessment and feedback system (iAx) was developed that electronically administers standardised instruments to patients with alcohol use disorder (AUD) for immediate interpretation.
References
More filters
Journal ArticleDOI
The PHQ-9: validity of a brief depression severity measure.
TL;DR: In addition to making criteria-based diagnoses of depressive disorders, the PHQ-9 is also a reliable and valid measure of depression severity, which makes it a useful clinical and research tool.
Journal ArticleDOI
A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research
Terry K. Koo,Mae Y. Li +1 more
TL;DR: A practical guideline for clinical researchers to choose the correct form of ICC is provided and the best practice of reporting ICC parameters in scientific publications is suggested.
Journal ArticleDOI
The Columbia–Suicide Severity Rating Scale: Initial Validity and Internal Consistency Findings From Three Multisite Studies With Adolescents and Adults
Kelly Posner,Gregory K. Brown,Barbara Stanley,David A. Brent,Kseniya V. Yershova,Maria A. Oquendo,Glenn W. Currier,Glenn A. Melvin,Laurence L. Greenhill,Sa Shen,J. John Mann +10 more
TL;DR: Findings suggest that the Columbia-Suicide Severity Rating Scale is suitable for assessment of suicidal ideation and behavior in clinical and research settings.
Journal ArticleDOI
Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies
Luis Sordo,Luis Sordo,Gregorio Barrio,María J. Bravo,B. Iciar Indave,Louisa Degenhardt,Louisa Degenhardt,Lucas Wiessing,Marica Ferri,Roberto Pastor-Barriuso +9 more
TL;DR: Retention in methadone and buprenorphine treatment is associated with substantial reductions in the risk for all cause and overdose mortality in people dependent on opioids.
Journal ArticleDOI
Validation of PHQ-2 and PHQ-9 to Screen for Major Depression in the Primary Care Population
Bruce Arroll,Felicity Goodyear-Smith,Sue Crengle,Jane Gunn,Ngaire Kerse,Tana Fishman,Karen Falloon,Simon Hatcher +7 more
TL;DR: The largest validation study of the 2- and 9-question Patient Health Questionnaires (PHQ-2 and PHQ-9) in primary care settings is reported, reporting good sensitivity but poor specificity in detecting major depression.